Investigating how RNA modifications affect DNA changes in B cells
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
This study is looking at how a special change in RNA helps B cells, which are important for our immune system, to create a variety of antibodies, with the hope that understanding this process can lead to better ways to boost our immune responses or prevent diseases linked to B cell problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11070736 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a specific RNA modification, N6-methyladenosine (m6A), in the processes that allow B cells to diversify their antibody genes. By examining how this modification influences DNA recombination and stability, the research aims to uncover mechanisms that could lead to better immune responses or prevent diseases related to B cell dysfunction. The study employs advanced molecular biology techniques to analyze RNA and DNA interactions in B cells, providing insights into their development and function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with known B cell disorders or those at risk for conditions involving B cell dysfunction.
Not a fit: Patients with non-B cell related conditions or those without any immune system disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for conditions related to B cell abnormalities, such as certain cancers or autoimmune diseases.
How similar studies have performed: Other research has shown promising results in understanding RNA modifications and their impact on cellular processes, suggesting that this approach could yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Basu, Uttiya — Columbia University Health Sciences
- Study coordinator: Basu, Uttiya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.